Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
PetVivo Holdings, Inc. is a biomedical device company specializing in innovative veterinary products, primarily targeting osteoarthritis in animals. Its core offerings include the Spryng intra-articular injection, leveraging proprietary biomaterials to promote joint tissue restoration. The company focuses on licensing, manufacturing, and commercializing animal therapeutics, with a pipeline extending to human applications. It operates through strategic distribution channels in the U.S. pet and equine markets.
This description was generated via AI from an annual report. Updated about 1 year ago.